Pulse.

a daily field guide to health research that matters

◆ Console

‹ Thu · 5 Nov 2026
Standard addition

The relationship of homocysteine and its redox forms with renal toxicity after high-dose methotrexate treatment in patients with leukemia or lymphoma.

Monitoring specific blood markers during chemotherapy could help identify which children face higher kidney damage risk early.

High-dose methotrexate (HD-MTX) chemotherapy inhibits dihydrofolate reductase, leading to impaired homocysteine metabolism, elevated levels, and associated clinical adverse reactions. In pediatric patients, Hcy/HHcy was significantly negatively correlated with creatinine (CR) (P < 0.

What the study was

Study design
Observational study
Population
Adult patients (see abstract)
Category
Treatment Innovation
Maturity
Validated
Journal
Frontiers in pharmacology

Why it surfaced

Design: Observational study; Topics: Hematologic malignancies; Species: human. Score=6/10.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.